See More Hear More Watch More Hear More Get on iTunes
TechCrunch TechCrunch

More Funding for Guardant360 Blood Test

Medical tech startup Guardant Health has finalized $50 million of additional funding for its new blood test Guardant360. The test is a biopsy free way to screen for breast, lung, skin, colorectal, and prostate cancers in real time. The test launched last year as the first of its kind. #tech


More from